These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23611593)

  • 1. B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants.
    Mine K; Ohashi A; Tsuji S; Nakashima J; Hirabayashi M; Kaneko K
    Acta Paediatr; 2013 Aug; 102(8):e347-52. PubMed ID: 23611593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
    Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?
    Lee JH; Shin JH; Park KH; Rhie YJ; Park MS; Choi BM
    Neonatology; 2013; 103(2):118-22. PubMed ID: 23182972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when?
    Liu Y; Huang ZL; Gong L; Zhang Z; Zhang SC; Zhou YX
    Clin Hemorheol Microcirc; 2020; 75(3):335-347. PubMed ID: 32280084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
    Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
    Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.
    Sanjeev S; Pettersen M; Lua J; Thomas R; Shankaran S; L'Ecuyer T
    J Perinatol; 2005 Nov; 25(11):709-13. PubMed ID: 16222347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH; Yang SN; Chen HL; Tseng HI; Dai ZK; Wu JR
    J Pediatr; 2010 Jul; 157(1):79-84. PubMed ID: 20227723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
    Rodriguez-Blanco S; Oulego-Erroz I; Gautreaux-Minaya S; Perez-Muñuzuri A; Couce-Pico ML
    J Perinatol; 2018 Jul; 38(7):881-888. PubMed ID: 29785059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P; Chongkongkiat P; Khositseth A
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P; Khositseth A; Thanomsingh P
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M; Gokulakrishnan G; Price J; Fernandes CJ; Leeflang M; Pammi M
    Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants.
    Puddy VF; Amirmansour C; Williams AF; Singer DR
    Clin Sci (Lond); 2002 Jul; 103(1):75-7. PubMed ID: 12095406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus.
    Oh SH; Lee BS; Jung E; Oh MY; Do HJ; Kim EA; Kim KS
    Sci Rep; 2020 Mar; 10(1):4430. PubMed ID: 32157119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of brain natriuretic propeptide in the diagnosis and management of patent ductus arteriosus].
    Montaner Ramón A; Galve Pradel Z; Fernández Espuelas C; Jiménez Montañés L; Samper Villagrasa MP; Rite Gracia S
    An Pediatr (Barc); 2017 Jun; 86(6):321-328. PubMed ID: 26936584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral oxygenation during different treatment strategies for a patent ductus arteriosus.
    Chock VY; Ramamoorthy C; Van Meurs KP
    Neonatology; 2011; 100(3):233-40. PubMed ID: 21701212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac biomarkers and haemodynamically significant patent ductus arteriosus in preterm infants.
    Weisz DE; McNamara PJ; El-Khuffash A
    Early Hum Dev; 2017 Feb; 105():41-47. PubMed ID: 27998626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks.
    Czernik C; Lemmer J; Metze B; Koehne PS; Mueller C; Obladen M
    Pediatr Res; 2008 Sep; 64(3):286-90. PubMed ID: 18414139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.